Regulatory enforcement on CBD and THC claims
The company markets hemp-derived wellness products that can attract FTC/FDA scrutiny.
- Scope
- Advertising, labeling, and product claims
- Materiality
- high
cbdMD, Inc. is a U.S.-based consumer products company that develops and sells hemp-derived wellness products under brands including cbdMD, Paw CBD, ATRx Labs, and Herbal Oasis. Its portfolio spans CBD tinctures, gummies, topicals, capsules, sleep and focus aids, functional mushroom products, and THC-infused beverages, sold through e-commerce, wholesale, and selected retail channels.
−9,4 %
62,4 %
−10,6 %
−1,5 %
2.05
1.13
| % | |
|---|---|
| CBD wellness products | 55% Broad-spectrum and full-spectrum hemp-derived CBD products for human use. |
| Pet wellness products | 10% CBD-based products sold under Paw CBD for pet health and wellness. |
| Functional mushroom and nootropic products | 10% ATRx Labs products focused on mushroom-based and cognitive wellness formulations. |
| THC beverages | 15% Herbal Oasis hemp-derived THC-infused ready-to-drink beverage products. |
| Wholesale and retail channel sales | 10% Sales through retail accounts, distributors, and other third-party channels. |
cbdMD sells primarily to consumers buying directly online, as well as wholesale and retail partners that stock its...
Buy CBD and wellness products online or by phone for convenience and brand selection.
Retailers and specialty chains buy branded SKUs to sell through physical stores.
Regional and category distributors buy products to expand market reach and placement.
Buy Paw CBD products for pet wellness and companion-animal use cases.
Buy through local wholesalers, legal partners, and e-commerce channels outside the U.S.
cbdMD is headquartered in Charlotte, North Carolina and operates primarily in the United States...
cbdMD is focused on expanding its revenue channels across direct-to-consumer, wholesale, and retail distribution while...
More retail and distributor placements increase product availability and brand scale.
Online sales depend on cost-effective customer acquisition and repeat purchasing.
Multiple brands can broaden the addressable market and reduce reliance on one product line.
Foreign markets can add growth, but require local regulatory navigation.
The business is exposed to regulatory scrutiny around hemp-derived cannabinoids, especially advertising and product...
The company markets hemp-derived wellness products that can attract FTC/FDA scrutiny.
Online sales rely on paid marketing and may become more expensive over time.
A history of operating losses can constrain investment and strategic flexibility.
Different jurisdictions may require reworks and reformulation of packaging materials.
Foreign sales require local legal counsel and market-specific approvals.
CWBHF · Agricultural Production-Crops
CVSI · Pharmaceutical Preparations
TCRG · Medicinal Chemicals & Botanical Products
CBDY · Medicinal Chemicals & Botanical Products
INM · Pharmaceutical Preparations
CNBX · Pharmaceutical Preparations
: 29/04/2026